Analyzing data from the Swedish Medical Birth Register, the Prescribed Drug Register, and the Swedish Neonatal Quality Register, researchers compared infants exposed to ADHD medication during pregnancy with infants whose mothers never used these drugs and infants whose mothers used ADHD medication before or after (but not during) pregnancy. Out of 964,734 infants included in […]
Tag Archives | stimulants and pregnancy
For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we often recommend discontinuing stimulant medications and switching to a non-pharmacologic intervention. Many women experience some decrease in their level of functioning; however, they are able to forgo or minimize pharmacologic treatment during pregnancy. There are, however, women who experience more severe symptoms which interfere […]
The article that received the most attention this week is one examining the risks associated with the use of stimulants to treat ADHD during pregnancy (Cohen JM et al, 2017). There were no real surprises here, but the study suffers from many of the same shortcomings as other studies investigating the effects of other psychotropic […]
Our group has noted that we are seeing an increase in the number of consultations for women treated with psychostimulants in combination with an antidepressant. The reasons vary. Some women have depression and comorbid attention-deficit/hyperactivity disorder (ADHD). Sometimes a psychostimulant is used to manage residual symptoms and side effects, such as fatigue and cognitive […]
Approximately 4% of the adult population suffers from ADHD. Attention and executive functioning difficulties also occur in those with mood and psychotic disorders and require treatment strategies similar to those used to address ADHD symptoms. First line medications most often used to treat ADHD in adults are Dextroamphetamine (Dexedrine, Adderall) and Methylphenidate (Concerta, Ritalin, Metadate).